Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.The Journal of Experimental Medicine|April 21, 2017
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2Andrea B Moffitt, Sarah L Ondrejka, Matthew McKinney, et al.Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.Cancer Discovery|April 21, 2026
SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilitiesBenedikt Pelzer, Cem Meydan, Isaac M Spiegel, et al.Cancer Discovery|January 27, 2017
The Genetic Basis of Hepatosplenic T-cell LymphomaMatthew McKinney, Andrea B Moffitt, Philippe Gaulard, et al.Cell|August 19, 2023
Epigenetic memory of coronavirus infection in innate immune cells and their progenitorsJin-Gyu Cheong, Arjun Ravishankar, Siddhartha Sharma, et al.Cell|October 7, 2017
Genetic and Functional Drivers of Diffuse Large B Cell LymphomaAnupama Reddy, Jenny Zhang, Nicholas S Davis, et al.Proceedings of the National Academy of Sciences of the United States of America|November 27, 2024
Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodesMichael J Topper, Joseph W Guarnieri, Jeffrey A Haltom, et al.Pageof 18